Status:
UNKNOWN
Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Ventricular Tachycardia
Eligibility:
All Genders
18+ years
Brief Summary
Sudden cardiac death is a frequent cause of cardiovascular mortality. Numerous rhythmic risk assessment criterion have been described targeting the substratum, the cardiac nervous tone or the trigger ...
Detailed Description
Sudden cardiac death is a frequent cause of cardiovascular mortality. Numerous rhythmic risk assessment criterion have been described targeting the substratum, the cardiac nervous tone or the trigger ...
Eligibility Criteria
Inclusion
- Patients undergoing ventricular tachycardia,
- patients with ischemic cardiomyopathy according to European Society of Cardiology Guidelines,
- patients with implanted cardiac defibrillator.
Exclusion
- Contra-indication to stress test,
- permanent atrial fibrillation,
- permanent ventricular pacing,
- left bundle block.
Key Trial Info
Start Date :
September 9 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03453645
Start Date
September 9 2017
End Date
February 1 2019
Last Update
July 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Toulouse
Toulouse, France, 31000